Cormorant Asset Management, LP's Form 4 filing
Immuneering Corp (IMRX) · filed Mar 18, 2024
- Accession no.
- 0000929638-24-001046
- Filed
- Mar 18, 2024, 5:59 PM ET
- Trade date
- Mar 14-15, 2024
- Filing delay
- 4 days
- Rule 10b5-1 plan
- Not checked
This filing lists 5 non-derivative transactions and 0 derivative transactions. Open-market sales total $2.75M. It was filed 4 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Cormorant Asset Management, LPCIK 0001583977 | 10% Owner |
| Chen BihuaCIK 0001599214 | 10% Owner |
| Cormorant Global Healthcare Master Fund, LPCIK 0001618442 | 10% Owner |
| Cormorant Private Healthcare Fund III LPCIK 0001817320 | 10% Owner |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Mar 14, 2024 | Class A Common Stock | SSaleDisposed | −345,266 | $3.24 | −$1,116,935.51 | 3,859,098 | Indirect | |
| Mar 14, 2024 | Class A Common Stock | SSaleDisposed | −98,570 | $4.25 | −$418,429.65 | 3,760,528 | Indirect | |
| Mar 14, 2024 | Class A Common Stock | SSaleDisposed | −54,215 | $5.37 | −$291,351.41 | 3,706,313 | Indirect | |
| Mar 14, 2024 | Class A Common Stock | SSaleDisposed | −11,040 | $5.97 | −$65,886.72 | 3,695,273 | Indirect | |
| Mar 15, 2024 | Class A Common Stock | SSaleDisposed | −400,000 | $2.14 | −$856,400 | 3,295,273 | Indirect |
Footnotes
Livermore does not store Form 4 footnotes. For price ranges, how indirect holdings are held and trading plan details, read the original on SEC EDGAR.